Skip to main content

Together we are beating cancer

Donate now

Cervical cancer

Cervical cancer is more common in younger women, with around 3,200 people diagnosed in the UK each year. It develops in the lining of the cervix – the lower part of the womb – and the main symptom is unusual or unexplained vaginal bleeding.
Showing 12 out of 110 results

Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician. Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician.

by Lilly Matson | Analysis | 27 April 2022

27 April 2022

A 3d rendered image of HPV cells

Wales announced changes to their routine cervical screening programme this week, moving from 3 to 5 years. We look at the science behind the switch. Wales announced changes to their routine cervical screening programme this week, moving from 3 to 5 years. We look at the science behind the switch.

by Alice Davies | Analysis | 7 January 2022

7 January 2022

That Cancer Conversation in a white speech bubble with a dark blue background

Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India 'eliminate' cervical cancer. Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India 'eliminate' cervical cancer.

by Cancer Research UK | Podcast | 9 December 2021

9 December 2021

This entry is part 4 of 17 in the series That Cancer Conversation
A photograph of a lady holding a vaccine and needle.

We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide. We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.

by Lilly Matson | In depth | 17 November 2021

17 November 2021

It’s completely up to you whether to go to cervical cancer screening. But the answers to these 6 questions could help you decide. It’s completely up to you whether to go to cervical cancer screening. But the answers to these 6 questions could help you decide.

by Rachel Orritt | Analysis | 25 October 2021

25 October 2021

Two people's feet in bed.

We want to have a conversation about human papillomavirus (HPV), starting with 6 questions about HPV people frequently ask our Cancer Research UK nurses. We want to have a conversation about human papillomavirus (HPV), starting with 6 questions about HPV people frequently ask our Cancer Research UK nurses.

by Karis Betts | Analysis | 16 June 2021

16 June 2021

Last year, the World Health Organisation (WHO) announced their plans to create a global strategy to accelerate the elimination of cervical cancer as a public health problem. Last year, the World Health Organisation (WHO) announced their plans to create a global strategy to accelerate the elimination of cervical cancer as a public health problem.

by Lilly Matson | Analysis | 19 April 2021

19 April 2021

HPV vaccine

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.   Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

by Cancer Research UK | News | 1 October 2020

1 October 2020

Test vials

Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating. Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating.

by Cancer Research UK | News | 22 January 2020

22 January 2020